1-5 of 5
Laura M. DeCastro, MD
Close
Sort by
Journal Articles

Pan-Selectin Antagonist Rivipansel (GMI-1070) Reduces Soluble E-Selectin Levels While Improving Clinical Outcomes in SCD Vaso-Occlusive Crisis

Ted Wun, MD, Marilyn J. Telen, MD, Lakshmanan Krishnamurti, MD, Timothy L. McCavit, MD, Laura M DeCastro, MD, Henry Flanner, ME, Frans A. Kuypers, PhD, Sandra K. Larkin, MS, Seungshin Rhee, MS, John L. Magnani, PhD, Helen M. Thackray, MD
Journal: Blood
Blood (2014) 124 (21): 2704.
https://doi.org/10.1182/blood.V124.21.2704.2704
Published: 2014
Journal Articles

Pan-Selectin Antagonist GMI-1070 Affects Biomarkers of Adhesion, Activation and the Coagulation Cascade in Sickle Cell Adults At Steady State

John L. Magnani, PhD, Frans A Kuypers, PhD, John T. Patton, PhD, Sandra K Larkin, MS, Lori Styles, MD, Laura M DeCastro, MD, Marilyn J. Telen, MD, Ted Wun, MD, Helen Thackray, MD
Journal: Blood
Blood (2012) 120 (21): 87.
https://doi.org/10.1182/blood.V120.21.87.87
Published: 2012
Journal Articles

Differences Between Hematologist and Hospitalist Caring for Patients with Sickle Cell Disease Hospitalized for Vaso-Occlusive Crisis,

Nirmish Shah, MD, Margo Renee Rollins, Daniel Landi, Regina Crawford, MD, Laura M DeCastro, MD
Journal: Blood
Blood (2011) 118 (21): 4185.
https://doi.org/10.1182/blood.V118.21.4185.4185
Published: 2011
Journal Articles

Resource Use and Expenditures Among Adult Sickle Cell Patients with and without Depression

Shital Kamble, PhD, Shelby D Reed, PhD, Charlene Flahiff, MS, Soheir Adam, MD, Laura M DeCastro, MD
Journal: Blood
Blood (2010) 116 (21): 1534.
https://doi.org/10.1182/blood.V116.21.1534.1534
Published: 2010
Journal Articles

Efficacy and Safety of the Gardos Channel Inhibitor, ICA-17043, in Patients with Sickle Cell Anemia.

Kenneth I. Ataga, MBBS, Laura M. DeCastro, MD, Paul Swerdlow, MD, Yogen Saunthararajah, MD, Wally Smith, MD, The ICA-17043 Study Investigators6
Journal: Blood
Blood (2004) 104 (11): 103.
https://doi.org/10.1182/blood.V104.11.103.103
Published: 2004